Whilst we focussed on hematological malignancies and T-ALL, this PI3K pharmacology dataset can be used as a resource for further interrogation and validation of PI3K pathway biology and sensitivity. The gene discussed is PIK3CB; the disease is acute lymphoblastic leukemia.